Download PDFPDF

Neonatal pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasia
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Neonatal pulmonary arteriovenous malformation
    • Fernando T V Amaral, pediatric cardiologist
    • Other Contributors:
      • Paulo R Félix, João A Granzotti, Lígia M S Rugolo, Tania A Bernardes, Marcos A Nunes

    Dear Editor

    As well emphasized by Koppen et al,[1] congenital pulmonary arteriovenous malformation presenting in the neonatal period is an exceedingly rare anomaly, perhaps underdiagnosed. The index of suspition should be high if appropriate treatment is to be offered to these babies and, unfortunately, this was not the case in a 6-day-old patient seen by us 7 years ago.[2] Adding to the severe hypoxaemia, o...

    Show More
    Conflict of Interest:
    None declared.